Blog Post

Webinar: What Providers Need to Know: New Medication Options in Behavioral Health

Jul 6th, 2021

Behavioral Drug Approvals in 2020

The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health conditions. What do providers need to know about these new medications?

Genoa Healthcare’s Chief Procurement Officer Stephanie Kornechuk, PharmD, recently hosted a webinar in which she addressed new behavioral drugs and their unique attributes. To learn more, watch the webinar, which:

Reviews 2020 behavioral drug approvals
Looks ahead at coming drug trends
Covers recent policy changes impacting treatment of opioid use disorder
Touches on recent COVID-19 vaccine developments

To learn more about how Genoa can help you and those you serve, contact us today.

Recent Posts

Blog Post

Commitment to community wellness: immunization clinics and health advocacy

In Jackson Miss., a dedicated Genoa pharmacy team led by site manager Stephanie Lidell, Pharm D, along with Stephanie Tucker and Justin Barnes, Business Development Representatives at Genoa Healthcare, organized...

Clinical Insights

Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...

Pharmacy Openings

Announcing three new pharmacy openings!

We’re excited to announce the opening of three pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

Blog Post

Mental health organizations to donate to this Giving Tuesday

Looking to make a difference this Giving Tuesday? Please consider donating to one of these mental health organizations. American Foundation for Suicide Prevention (AFSP): AFSP is a national charity that supports...